Back to Browse Journals » Patient Preference and Adherence » Volume 2

Patient’s compliance with allergen immunotherapy

Authors Cristoforo Incorvaia, Marina Mauro, Erminia Ridolo, Paola Puccinelli, Massimiliano Liuzzo, et al

Published Date September 2008 Volume 2008:2 Pages 247—251

DOI http://dx.doi.org/10.2147/PPA.S3806

Published 15 September 2008

Cristoforo Incorvaia1, Marina Mauro2, Erminia Ridolo3, Paola Puccinelli4, Massimiliano Liuzzo4, Silvia Scurati4, Franco Frati4,5

1Allergy/Pulmonary rehabilitation Unit, ICP Hospital, Milan, Italy; 2Allergy Unit, Sant’Anna Hospital, Como, Italy; 3University Department of Clinical Sciences, Parma, Italy; 4Medical and Scientific Department, Stallergenes, Milan, Italy; 5Pediatrics, University Department of Medical and Surgical Specialty and Public Health, Perugia, Italy

Background: Allergen immunotherapy (IT) is an effective treatment of respiratory allergy, but requires strict rules of performance. This makes compliance particularly relevant, but thus far only a few studies have investigated this issue.

Methods: We reviewed all the available articles on compliance and adherence with IT in its different forms of administration, ie, subcutaneous (SCIT), sublingual (SLIT), and local nasal (LNIT).

Results: Early studies, when only SCIT was available, reported a low compliance, ranging from 45% to 60%, but the demanding schedules used, with very frequent injections, accounted for this outcome, as shown by patients’ recognition of inconvenience as the major cause of noncompliance. The most recent studies reported a good compliance, estimated in 75% to 90%, to both SCIT and SLIT, inconvenience remaining the major cause of noncompliance, followed by cost of the treatment. The only study addressing LNIT found a very poor compliance (27%), the major cause being the side effects, with repeated nasal reactions to the allergen extract.

Conclusions: Adequate education of patients and optimization of administration schedules, with fine balancing between dose effectiveness and cost, are the factors most likely to achieve further improvement of compliance with IT.

Keywords: allergen immunotherapy, subcutaneous, sublingual, local nasal, compliance, adherence

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other articles by this author:

Effect of noninvasive mechanical ventilation in elderly patients with hypercapnic acute-on-chronic respiratory failure and a do-not-intubate order

Paolo Scarpazza, Cristoforo Incorvaia, Giuseppe di Franco, Stefania Raschi, Pierfranco Usai, et al

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:797-801

Published Date: 30 October 2008

Current and future applications of the anti-IgE antibody omalizumab

Cristoforo Incorvaia, Marina Mauro, Gian Galeazzo Riario-Sforza, Franco Frati, Francesco Tarantini, Maurizio Caserini

Biologics: Targets and Therapy 2008, 2:67-73

Published Date: 26 March 2008

Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium

Cristoforo Incorvaia, Gian Galeazzo Riario-Sforza, Chiara Pravettoni, Mona-Rita Yacoub, Franco Frati

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:123-126

Published Date: 18 March 2008

Readers of this article also read:

Navigated focal laser photocoagulation for central serous chorioretinopathy

Chhablani J, Rani PK, Mathai A, Jalali S, Kozak I

Clinical Ophthalmology 2014, 8:1543-1547

Published Date: 18 August 2014

Periorbital muscle atrophy associated with topical bimatoprost therapy

Wang PX, Koh VT, Cheng JF

Clinical Ophthalmology 2014, 8:311-314

Published Date: 29 January 2014

Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers

Zhao YQ, Wang LP, Ma C, Zhao K, Liu Y, Feng NP

International Journal of Nanomedicine 2013, 8:4169-4181

Published Date: 31 October 2013

Positively charged cholesterol–recombinant human gelatins foster the cellular uptake of proteins and murine immune reactions

Kadengodlu PA, Hebishima T, Takeshima SN, Ito M, Liu M, Abe H, Aida Y, Aigaki T, Ito Y

International Journal of Nanomedicine 2012, 7:5437-5450

Published Date: 11 October 2012

Psychopharmacology of topiramate: from epilepsy to bipolar disorder

Marco Mula, Andrea E Cavanna, Francesco Monaco

Neuropsychiatric Disease and Treatment 2006, 2:475-488

Published Date: 27 February 2006